USD 19.55 Billion
Medical Imaging Reagents Market Size, Share, Growth Analysis, By Class(Contrast Reagents, Optical Reagents, Nuclear Reagents), By Technology(Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins), By Application(Dignostic, Drug discovery & Technology, Educational Research), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2744 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|Tables:
65
|Figures:
80
Medical Imaging Reagents Market Insights
Global Medical Imaging Reagents Market size was valued at USD 19.55 Billion in 2022 and is poised to grow from USD 21.35 Billion in 2023 to USD 43.17 Billion by 2031, at a CAGR of 9.20% during the forecast period (2024-2031).
The worldwide scientific imaging reagents market is a critical segment of the healthcare enterprise, offering important gear for diagnostic and studies purposes. Medical imaging reagents are materials that beautify the comparison and visibility of precise tissues or organs in medical imaging techniques consisting of magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and nuclear medication. Key drivers of this marketplace consist of the growing occurrence of continual sicknesses, a growing getting older populace, and the want for early and accurate disorder prognosis. Medical imaging reagents play a pivotal role in improving diagnostic accuracy and remedy planning, thereby helping in better affected person results. In recent years, there has been an exceptional shift closer to molecular imaging techniques, which offer functional and metabolic records along anatomical pictures. This has spurred the call for advanced imaging reagents which can target specific molecules and pathways, allowing for better disorder characterization and customized remedy strategies. The market is also witnessing ongoing studies and development efforts to create more secure and extra green reagents, along with those with minimal toxicity and longer half-life. Furthermore, the adoption of hybrid imaging systems that combine a couple of imaging modalities, together with PET/CT and SPECT/CT, is using the demand for versatile reagents that can be used throughout numerous systems.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Contrast Reagents
Fastest Growth
Contrast Reagents
Growth Rate
9.20% CAGR
Global Medical Imaging Reagents Market ($ Bn)
Country Share North America for Region (%)
To get more reports on the above market click here to Buy The Report
Medical Imaging Reagents Market Segmental Analysis
The global medical imaging reagents market is segmented on the basis of class, technology, application and region. By class, the market is segmented into Contrast Reagents, Optical Reagents, and Nuclear Reagents. By technology, the market is segmented into Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots. By application, the market is segmented into Diagnostics, Drug Discovery & Development, Educational Research. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis By Class
In the global clinical imaging reagents marketplace, the dominant segment is evaluation reagents. These are vital additives in medical imaging, as they decorate the visibility of particular tissues or organs throughout diagnostic methods. These reagents are commonly used in various imaging modalities, together with computed tomography (CT), magnetic resonance imaging (MRI), and X-ray. The dominant function of evaluation reagents is often because of their significant utility throughout distinct clinical specialties, along with radiology, cardiology, and oncology. Constant improvements in evaluation reagents, such as the development of low-osmolality evaluation agents with reduced facet effects, have contributed to their dominance within the market. Increasing incidence of continual diseases and the developing aging populace, which require common clinical imaging for diagnosis and tracking, similarly force the call for assessment reagents.
On the opposite hand, the quickest-developing phase within the international clinical imaging reagents market is Optical Reagents. Optical reagents, which encompass fluorescent dyes and molecular probes, are experiencing fast growth in the clinical imaging reagents marketplace. The adoption of optical imaging strategies, inclusive of fluorescence imaging and bioluminescence imaging, has been progressively increasing for both in vitro and in vivo applications. Optical reagents offer blessings like high sensitivity, actual-time imaging capabilities, and the capability to target specific biomolecules. These functions make them increasingly attractive for research and scientific programs. Applications of optical reagents variety from cancer detection and tracking cellular strategies to studying protein-protein interactions and drug development. The non-stop improvement of novel optical reagents with progressed residences and specificity is anticipated to pressure the growth of this phase even similarly inside the coming years.
Analysis By Technology
In the worldwide clinical imaging reagents market, Radiopharmaceuticals will be the dominant segment. Radiopharmaceuticals are compounds containing a radioactive isotope that may be used for diagnostic imaging and healing functions in nuclear remedy. They are broadly utilized for various scientific imaging applications, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. The capability to offer valuable diagnostic facts for a number of medical situations, inclusive of cancer, cardiovascular diseases, and neurological issues, makes radiopharmaceuticals a dominant and essential era in medical imaging.
On the other hand, the Quantum Dots phase is the fastest-growing inside the worldwide clinical imaging reagents market. Quantum dots are nanometer-sized semiconductor particles that exhibit unique optical residences. They have gained traction due to their capacity in turning in excessive-decision and multiplexed imaging in scientific programs. Quantum dots offer benefits like superior brightness, photostability, and tunable emission wavelengths, making them increasingly more famous for cell and molecular imaging, in addition to in-vivo imaging. As researchers and medical professionals continue to discover new approaches to beautify diagnostic and research abilities, the demand for quantum dots in scientific imaging is expected to enjoy a speedy boom within the coming years.
Global Medical Imaging Reagents Market By Class
To get detailed analysis on other segments, Request For Free Sample Report
Medical Imaging Reagents Market Regional Insights
The international clinical imaging reagents market is analyzed based totally on its regional presence, which includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America, mainly the US, has been the dominant area inside the global medical imaging reagents market. Factors contributing to its dominance include a well-hooked up healthcare infrastructure, high healthcare spending, and good sized studies and improved sports within the area of scientific imaging. The presence of leading pharmaceutical and biotechnology corporations, in addition to a huge wide variety of instructional studies institutions, drives the demand for scientific imaging reagents in this place. Additionally, the growing prevalence of continual illnesses, along with cancer and cardiovascular illnesses, has brought about elevated utilization of clinical imaging technology, further fueling the call for imaging reagents.
As for the quickest developing segment, the Asia-Pacific region, with countries like China, India, and Japan, is anticipated to be the fastest-developing vicinity within the international clinical imaging reagents market. This growth can be attributed to several elements: Rapidly expanding healthcare infrastructure and growing healthcare expenditure in emerging economies. Growing attention to early sickness diagnosis and a rising center-elegance population with more get admission to healthcare offerings. Increasing investments in scientific studies and development, main to greater adoption of advanced scientific imaging technology. Government projects and collaborations with international pharmaceutical companies to improve healthcare get right of entry to and consequences.
Global Medical Imaging Reagents Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Medical Imaging Reagents Market Dynamics
Drivers
Growing Incidence of Chronic Diseases:
- The increasing prevalence of continual sicknesses consisting of most cancers, cardiovascular problems, and neurological conditions has caused a better demand for scientific imaging tactics. Medical imaging reagents play a critical position in improving the accuracy and effectiveness of diagnostic imaging techniques, riding their adoption.
Advancements in Imaging Technologies:
- Ongoing advancements in scientific imaging technology, inclusive of positron emission tomography (PET), magnetic resonance imaging (MRI), and computed tomography (CT), have brought about the development of novel imaging reagents that offer stepped forward sensitivity and specificity. These innovations have extended the applications of clinical imaging reagents, creating possibilities for marketplace boom.
Restraints
High Costs:
- Medical imaging reagents, in particular those utilized in advanced imaging modalities like PET and MRI, may be pricey. The price of reagents, devices, and associated healthcare offerings can be an extensive monetary burden for healthcare centers and sufferers alike. This price barrier can restrict marketplace boom, especially in lower-income areas.
Regulatory Challenges:
- The medical imaging reagents marketplace is difficult to meet stringent regulatory requirements and approvals, as these products at once affect patient prognosis and treatment. Navigating the complicated regulatory landscape may be time-consuming and expensive for manufacturers, mainly due to delays in product launches and marketplace access. Moreover, adjustments in regulatory guidelines can also pose challenges to market gamers.
Request Free Customization of this report to help us to meet your business objectives.
Medical Imaging Reagents Market Competitive Landscape
The global medical imaging reagents market is characterized by severe competition and a dynamic landscape. Several key gamers dominate this marketplace, usually striving for innovation, strategic collaborations, and acquisitions to maintain or decorate their aggressive positions. Companies like GE Healthcare, Siemens Healthineers, and Thermo Fisher Scientific are important gamers with assorted portfolios of imaging reagents utilized in diverse diagnostic imaging modalities, inclusive of MRI, CT, PET, and ultrasound. They focus on product improvement and expanding their geographical presence through partnerships and acquisitions. Furthermore, there are specialized players like Bracco Imaging and Lantheus Holdings, which excel in contrast marketers for unique imaging modalities. The market additionally witnesses the entry of smaller, innovative startups developing novel reagents and technology. These beginners contribute to marketplace dynamism by introducing disruptive solutions.As the demand for medical imaging continues to grow with an aging population and increased diagnostic needs, competition in the medical imaging reagents market is expected to remain robust. Success will depend on a company's ability to adapt to evolving healthcare trends, meet regulatory requirements, and provide reliable and safe reagents for medical imaging applications.
Top Player’s Company Profile
- GE Healthcare (USA)
- Siemens Healthineers (Germany)
- Thermo Fisher Scientific (USA)
- Bayer AG (Germany)
- Bracco Imaging S.p.A. (Italy)
- Lantheus Medical Imaging (USA)
- Mallinckrodt Pharmaceuticals (USA)
- Koninklijke Philips N.V. (Netherlands)
- Fujifilm Holdings Corporation (Japan)
- PerkinElmer (USA)
- Hologic, Inc. (USA)
- EliTechGroup (France)
- Curium Pharma (France)
- NanoScan Imaging (USA)
- Eisai Co., Ltd. (Japan)
- J.B. Chemicals & Pharmaceuticals Ltd. (India)
- Nordion Inc. (Canada)
- Jubilant Life Sciences Ltd. (India)
- Astellas Pharma, Inc. (Japan)
- Cyclopharm Ltd. (Australia)
- Cardinal Health, Inc. (USA)
- Life Molecular Imaging (Germany)
- AdvaCare Pharma (USA)
- The Medical House PLC (UK)
- Lumiphore, Inc. (USA)
Recent Developments
- In January 2023, Bayer announced that it has obtained FDA acclaim for its new gadolinium-unfastened evaluation agent, gadopiclenol. Gadopiclenol is the primary gadolinium-unfastened assessment agent to be approved to be used in MRI imaging of the brain, backbone, and frame.
- In February 2023, Siemens Healthineers announced that it has evolved a brand new AI-powered algorithm that could come across breast cancer in mammograms more accurately than human radiologists. The algorithm remains in improvement, but it has the capability to improve the early detection of breast cancer.
- In March 2023, GE Healthcare announced that it is developing a brand new molecular imaging agent for the analysis of Alzheimer's disease. The agent targets amyloid beta, a protein that is thought to play a function in the development of Alzheimer's disease.
- In April 2023, Illumina announced that it is developing a new personalized medicinal drug platform that makes use of molecular imaging to identify the precise form of tumor that an affected person has. The platform continues to be in improvement, however it has the ability to improve the remedy of most cancers.
Medical Imaging Reagents Key Market Trends
- Growing Demand for Molecular Imaging Agents: Molecular imaging reagents, which includes positron emission tomography (PET) and unmarried-photon emission computed tomography (SPECT) radiopharmaceuticals, were experiencing increasing call for. These reagents permit the visualization and quantification of organic procedures at the molecular and cell levels, aiding in early disease detection, remedy making plans, and tracking. Advancements in radiopharmaceutical development, together with the improvement of extra centered and unique marketers, have contributed to this trend.
- Shift Towards Contrast-Enhanced Ultrasound (CEUS): Ultrasound imaging is one of the most extensively used imaging modalities in healthcare. One tremendous trend in the scientific imaging reagents market has been the developing adoption of contrast-enhanced ultrasound (CEUS) dealers. CEUS entails the use of microbubble evaluation sellers to enhance the visibility of blood float and tissue perfusion in ultrasound photos. This generation is taken into consideration more secure than traditional contrast-improved imaging methods like CT and MRI, which use iodinated contrast agents or gadolinium-primarily based contrast sellers, respectively. CEUS has found programs in diverse clinical specialties, inclusive of cardiology, oncology, and gastroenterology.
Medical Imaging Reagents Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our international medical imaging reagents marketplace evaluation, the marketplace has experienced vast growth in current years, pushed by advances in scientific imaging technology, extended occurrence of continual sicknesses, and growing demand for early and accurate diagnosis. Medical imaging reagents, which include contrast agents and radiopharmaceuticals, play an essential role in enhancing the visibility of anatomical structures and abnormalities in diverse imaging modalities like MRI, CT, and nuclear medicinal drugs. One of the number one drivers of this market's boom is the expanding utility of clinical imaging in prognosis and treatment making plans. The getting older population, with a higher susceptibility to diseases like cancer and cardiovascular problems, has further boosted the call for clinical imaging approaches. Technological improvements, along with the improvement of safer and extra green contrast agents, have progressed the niece of medical imaging, lowering the dangers related to conventional methods. Moreover, the growing occurrence of chronic illnesses has caused a more need for non-invasive diagnostic strategies, using the call for medical imaging reagents. The worldwide pandemic also underscored the importance of diagnostic imaging inside the healthcare system.
Despite the market's boom ability, challenges like regulatory hurdles and worries approximately the protection of contrast retailers continue to be. Companies are investing in studies and improvement to overcome those demanding situations and introduce innovative reagents. In conclusion, the global clinical imaging reagents marketplace is poised for persisted growth, pushed with the aid of technological advancements and the growing burden of persistent diseases. Investments in studies and improvement, along with a focus on safety and regulatory compliance, could be vital for sustained success in this market.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 19.55 Billion |
| Market size value in 2031 | USD 43.17 Billion |
| Growth Rate | 9.20% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Medical Imaging Reagents Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Medical Imaging Reagents Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Medical Imaging Reagents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Medical Imaging Reagents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Medical Imaging Reagents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Medical Imaging Reagents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
